Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies.
Abstract
- PMID:
25409697
[PubMed – as supplied by publisher]
Publication Types, MeSH Terms, Substances, Grant Support
Publication Types
MeSH Terms
- Animals
- Cannabis/adverse effects*
- Cell Differentiation/drug effects
- Cell Differentiation/physiology
- Endocannabinoids/metabolism*
- Female
- Humans
- Neurogenesis/drug effects
- Neurogenesis/physiology*
- Neurons/cytology
- Neurons/drug effects
- Neurons/metabolism*
- Pregnancy
Substances
Grant Support
LinkOut – more resources
Full Text Sources
- Figure 1: Molecular architecture of the endocannabinoid system during synaptogenesis and at mature synapses.
Neuronal and glial components of developing and mature synapses are shown. The molecular architecture shown here is for a ‘stereotypical’ synapse that uses endocannabinoid signalling. There are differences in neurotransmitter system-spe…
Figure 2: Molecular architecture of endocannabinoid signalling during corticogenesis, including neurogenesis and neuronal migration.
a | During mid or late gestation in rodents, 2-arachidonoylglycerol (2-AG)-rich cortical microdomains are thought to repulse postmitotic neurons that express cannabinoid 1 receptors (CB1Rs), including radially migrating pyramidal cells…Figure 3: Design logic of endocannabinoid signalling during neurite outgrowth and synaptogenesis.
a | Signal transduction mechanisms implicated in the cannabinoid 1 receptor (CB1R)-mediated control of cortical neuron specification and morphological differentiation are shown. Activation of tyrosine kinase receptors (particularly the…Figure 4: Defective development of the corticofugal system following genetic manipulation of CB1Rs.
Conditional deletion204 of cannabinoid 1 receptors (CB1Rs) from mouse cortical pyramidal cells results in errant corticofugal axon fasciculation compared with wild-type controls (shown by arrows). Note that enlarged axon fascicles (enci…Figure 5: Dysregulation of cannabinoid receptor signalling in glioma cells.
a | In neural progenitor cells, endocannabinoid (eCB) binding to cannabinoid receptors couples to the phosphatidylinositol 3-kinase (PI3K)–AKT–mammalian target of rapamycin complex 1 (mTORC1) pathway via Giproteins. Receptor tyrosine k…
Other Literature Sources